Researchers set to test MD compound

Published: Sept. 7, 2009 at 8:39 PM

CHAMPAIGN, Ill., Sept. 7 (UPI) -- University of Illinois researchers will soon test a molecule they say may be a breakthrough in the fight against the most common form of muscular dystrophy.

The new compound binds tightly to an abnormally elongated RNA that disrupts normal cellular machinery and brings on symptoms of the disease, myotonic dystrophy type 1, the university, in Champaign, Ill., said in a press release.

Myotonic dystrophy type 1 affects about one in 8,000 people. It is a muscle degeneration disease that may be mild or may lead to a debilitating loss of muscle control and declines in organ function.

The primary cause of the disease, scientists say, is a mutant gene that contains too many repeats of the chemical letters that spell out the sequence of a gene.

"The longer the repeat the worse the disease and the earlier the onset of the disease," Illinois chemistry department head Steven Zimmerman said.

He was a co-leader of the research with his colleague, chemistry Professor Anne Baranger.

© 2009 United Press International, Inc. All Rights Reserved.
Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.

Order reprints




Additional News Stories
Canada faces must-win in hockey
Your Daily Horoscope
The almanac
Empty Nest: Music-making with Riley!
Texas evidence barred from Ariz. trial
Alaska mulls new ethics rules post-Palin
Md. report optimistic about wind power
fark
47-year old teacher facing jail for going topless for teen (with non-topless pic)
Stephen Colbert: "Sarah Palin is a f*cking retard"
Photoshop this artificial appendage
Illegal immigration dropped 7 percent last year on news that US sucks almost as much as Mexico these...
Thanks to union contracts, a Madison, Wisconsin bus driver earned $159,258 last year. Step to the...
Woman charged with impersonation. Of Jabba The Hutt, apparently